Central blood pressure as a risk marker for cardiovascular complications;Ciśnienie centralne jako wskaźnik ryzyka powikł ań sercowo-naczyniowych

Nadcisnienie Tetnicze

Volumn 10, Issue 5, 2006, Pages 341-349

  Pȩdzich, Ewa ^a   Szmigielski, Cezary ^a   Gaciong, Zbigniew ^a,b  

^a Katedra i Klinika Chorob Wewnetrznych Nadcisnienia Tetniczego i Angiologii   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Arterial stiffness; Augmentation index; Central arterial pressure; Pulse wave

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AORTA; ARTERY OCCLUSION; BLOOD PRESSURE MEASUREMENT; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL TRIAL; HUMAN; HYPERTENSION; REVIEW;

EID: 33750390422     PISSN: 14285851     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Blacher J., Asmar R, Djane S., London G.M., Safar M.E. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33: 1111-1117.
2. Zaja̧c M., Drożdż J., Kurpesa M., Trzos E., Rechciński T. Nieinwazyjna ocena podatności tȩtnic. Forum Kardiologów 2004; 9 (3): 79-87.
3. Gryglewska B., Grodzicki T., Ga̧sowski J., Piejko A., Kocemba A. Sztywność naczyń a wahania ciśnienia tȩtniczego u osób z nadciśnieniem tȩtniczym. Nadciśnienie tȩtnicze 1999; 3 (4): 221-226.
4. Cwynar M., Wojciechowska W., Kawecka-Jaszcz K., Grodzicki T. Mechanizmy przebudowy dużych naczyń tȩtniczych. Przegl. Lek. 2002; 59 (supl. 3): 1-8.
5. Rajzer M., Kawecka-Jaszcz K. Podatność tȩtnic w nadciśnieniu tȩtniczym. Od patofizjologii do znaczenia klinicznego. Nadciśnienie Tȩtnicze 2002; 6 (1): 61-73.
6. Laurent S., Boutouyrie P., Lacolley. Strukturalne i genetyczne podłoże sztywnościtȩtnic. Hypertension 2005;45:1050-1055.
7. Matsui Y., Kario K., Ishikawa J., Eguchi K., Hoshide S., Shimada K. Reproducibility of arterial stiffness indices (pulse wale velocity and augmentation index) simultaneously assessed by automatem pulse wale analysis and their associated risk factors in essential hypertensive patients. Hypertens. Res. 2004; 27: 851-857.
8. Cockcroft J.R., Webb D.J., Wilkinson I.B. Arterial stiffness, hypertension and diabetes mellitus. J. Hum. Hypertens. 2000; 14: 377-380.
9. O'Rourke M.F., Adji A. An updated clinical primer on large artery mechanics: implications of pulse waveform analysis and arterial tonometry. Curr. Opin. Card. 2005; 20: 275-281.
10. Mandecki J. Kardiologia. PZWL, wydanie I, Warszawa 2000.
11. Cameron J.D., McGrath B.P., Dart A.M. Use of artery applanation tonometry and a generalized transfer function to determine aortic pressure augmentation in subjects with treated hypertension. J. Am. Coll. Cardiol. 1998; 32: 1214-1220.
12. Wojciechowska W., Cwynar M., Gryglewska B., Kawecka-Jaszcz K. Analiza fali tȩtna: od podstaw do zastosowań. Przegl. Lek. 2002; 59 (supl. 3): 9-14.
13. Woodman R.J., Watts G.F. Measurement and application of arterial stiffness in clinical research: focus on new methodologies and diabetes mellitus. Med. Sci. Monit. 2003; 9 (5): RA101-109.
14. Chirinos J.A., Zambrano J.P., Chakko S. i wsp. Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease. Hypertension 2005; 45: 980-985.
15. Oliver J.J., Webb D.J. Noninvasive Assessment of Arterial Stiffness and Risk of Atherosclerotic Events. Arterioscler. Thromb. Vasc. Biol. 2003; 23: 554-566.
16. Asmar R., Benetos A., Topouchuan J. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Hypertesion 1995; 26: 485-490.
17. Ramos E., Perez-Quintero J.A., Encinas S.M. i wsp. Carotid-femoral pulse wave velocity in children and adolescents from 2-18 years. Hypertension 2004; 43: 163-170.
18. Tomiyama H., Arai T., Koji Y., Yabe M. i wsp. The age-related increase in arterial stiffness is augmented in phases according to the severity of hypertension. Hypertens. Res. 2004; 27: 465-470.
19. Sa Cunha R., Pannier B., Benetos A. Associations between high heart rate and arterial rigidity in normotensive and hypertensive subjects. J. Hypertens. 1997; 15: 1423-1433.
20. Cloud G.C., Rajkumar C., Kooner J., Cooke J., Bulpitt C.J. Estimation of central aortic pressure by ShygmoCor requires intra-arterial peripheral pressures. Clinical Science 2003; 105: 219-225.
21. London G.M., Marchais S.J., Guerin A.P., Metivier F. Impairment of arterial function in chronic renal disease: prognostic impact and therapeutic approach. Nephrol. Dial. Transplant. 2002; 17: 13-15.
22. Czarnecka D., Zabojszcz M. Przebudowa naczyń a ryzyko powikłań sercowo-naczyniowych. Przegl. Lek. 2002; 59 (supl. 3): 15-24.
23. Waluś-Miarka M., Czarnecka D., Kawecka-Jaszcz K. i wsp. Prȩdkość fali tȩtna a wybrane czynniki ryzyka choroby niedokrwiennej serca u pacjentów z cukrzya̧ typu 2. Przegl. Lek. 2005; 62: 46-48.
24. Covic A., Haydar A.A., Bharma-Ariza P., Gusbeth-Tatomir P., Goldsmith D.J. Aortic pulse wave velocity and arterial wave reflections predict the extent and severity of coronary artery disease in chronic kidney disease patients. J. Nephrol. 2005; 18: 388-396.
25. Van Bortel L.M., Struijker-Boudier H.A., Safar M.E. Pulse pressure, arterial stiffness, and drug treatment of hypertension. Hypertension 2001; 38 (4): 914-21.
26. Sandrine C. Millasseau, Sundip J. i wsp. Pressure wave reflection assessed from the peripheral pulse: is a transfer function necessary? Hypertension 2003; 41: 1016-1020.
27. Kass D.A., Shapiro E.P., Kawaguchi M. i wsp. Improved arterial compliance ny a novel advanced glycation end-product crosslink breaker. Circulation 2001; 104: 1464-1470.
28. Nichols W.W. Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms. Am. J. Hypertens. 2005; 18: 3S-10S.
29. Williams B., Lacy P.S., Thom S.M i wsp.; CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal cresults of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113 (9): 1213-1225.
30. Sever P.S., Dahlöf B., Poulter N.R. i wsp. for the ASCOT investigators. Prevention of coronary and stroke events with atorvastation in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. The Lancet 2003; 361: 1149-1158.
31. Asmar R.G., London G.M., O'Rourke M.E., Safar M.E., for the REASON project coordinators and investigators. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patients: a comparison with atenolol. Hypertension 2001; 38: 922-996.
32. Morgan T., Lauri J., Bertram D., Anderson A. Effect of different antihypertensive drug classes on central aortic pressure. Am. J. Hypertens. 2004; 17 (2): 118-123.
33. Airaksinen K.E., Salmela P.I., Linnaluoto M.K. Diminished arterial elasticity in diabetes: Association with fluorescent advanced glycosylation and products in collagen. Cardiovascular Res. 1993; 27: 942-945.
34. Wautier J.L., Schmidt A.M. Protein glycation - a firm link to endothelial cell dysfunction. Circ. Res. 2004; 95: 233-238.
35. Aoun S., Blacher J., Safar M.E., Mourad J.J. Diabetes mellitus and renal failure: effects on large artery stiffness. J. Hum. Hypertens. 2001; 15: 693-700.
36. Blacher J., Guerin A.P., Pannier B., Marchais S.J., Safar M.E., London G.M. Impact of Aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434-2439.